Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for quarter ended March 31, 2026
KPL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kwality Pharmaceuticals has filed a compliance certificate confirming that its Registrar and Share Transfer Agent, Bigshare Services Private Limited, properly processed all securities received for dematerialization up to March 31, 2026. The certificate verifies that share certificates were mutilated and cancelled after due verification, and that depositories were substituted as registered owners in the register of members within the required 15-day timeframe. This is a routine regulatory filing required under SEBI regulations for all listed companies. The filing was submitted to BSE on April 8, 2026.
This is a standard compliance filing with no direct impact on company financials or operations. It provides assurance that share dematerialization procedures are being followed correctly, which is routine for listed companies.